Long before COVID 19 and remote work, there was the USPTO ‘hoteling’ system. It started in 1997 with 18 employees, and ...

The US Patent and Trademark Office told a group of specialized patent judges on Tuesday afternoon they could be expected to ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Some teleworking patent examiners at the US Patent and Trademark Office have less than a week to return to agency offices in ...

Adam Fowles, Dirk Bernhardt and Brett Bostrom of Haynes Boone discuss preparing a revival petition for patents or ...

They're almost always made of metal, and even with spinners and floaters, you're restricted to one design at a time. Wheel ...

The U.S. Supreme Court has once again been urged to revisit 35 U.S.C. § 101, the statute governing patent eligibility. Audio ...

Aprea Therapeutics (APRE) provided an update on its existing patent portfolio. Aprea’s ATR inhibitor program is protected by ...

Lucid Motors grew their market presence with a 50% sales increase in January following the Gravity electric SUV launch, but ...

Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028, The ...

Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...